OxRML/AgentSLR huggingface dataset:
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 2.7
Unit: No units
Epidemic phase: Mid outbreak
Reproduction number method: Growth rate
Population group: General population
Sample type: Population based
Country: Singapore
Location: Singapore
Study period: 17 Mar-03 2003 to 15 May-05 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 2.1
Unit: No units
Epidemic phase: Mid outbreak
Reproduction number method: Growth rate
Population group: General population
Sample type: Population based
Country: Hong Kong SAR,  China
Location: Hong Kong
Study period: 17 Mar-03 2003 to 15 May-05 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 3.8
Unit: No units
Epidemic phase: Mid outbreak
Reproduction number method: Growth rate
Population group: General population
Sample type: Population based
Country: China
Location: Beijing
Study period: 17 Mar-03 2003 to 15 May-05 2003
Pathogen: SARS-CoV
Parameter class: Mutations
Parameter type: Mutations – substitution rate
Unit: Substitutions/site/year
Lower bound: 0.8
Upper bound: 2.38
Bounds: 0.8 - 2.38
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Unspecified
Sex: Unspecified
Sample size: 11
Country: Hong Kong SAR,  China, Singapore
Location: Hong Kong, Singapore, Other
Study period: 14 Apr-04 2003 to 29 Aug-08 2003
Pathogen: SARS-CoV
Parameter class: Mutations
Parameter type: Mutations – mutation rate
Unit: Substitutions/site/year
Lower bound: 0.42
Upper bound: 2.38
Bounds: 0.42 - 2.38
Epidemic phase: Mid outbreak
Disaggregated by: Method, Region
Population group: Persons under investigation
Sample type: Unspecified
Sex: Unspecified
Sample size: 16
Country: China, Hong Kong SAR,  China, Singapore
Location: China, Hong Kong, Singapore, Other
Study period: 14 Apr-04 2003 to 29 Aug-08 2003
Pathogen: SARS-CoV
Parameter class: Mutations
Parameter type: Mutations – substitution rate
Unit: Substitutions/site/year
Lower bound: 0.81
Upper bound: 9.22
Bounds: 0.81 - 9.22
Epidemic phase: Mid outbreak
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Unspecified
Sex: Unspecified
Sample size: 16
Country: China, Hong Kong SAR,  China, Singapore
Location: China, Hong Kong, Singapore, Other
Study period: 14 Apr-04 2003 to 29 Aug-08 2003
Genome site: non-synonymous sites
Pathogen: SARS-CoV
Parameter class: Mutations
Parameter type: Mutations – substitution rate
Unit: Substitutions/site/year
Lower bound: 0
Upper bound: 8.5
Bounds: 0 - 8.5
Epidemic phase: Mid outbreak
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Unspecified
Sex: Unspecified
Sample size: 16
Country: China, Hong Kong SAR,  China, Singapore
Location: China, Hong Kong, Singapore, Other
Study period: 14 Apr-04 2003 to 29 Aug-08 2003
Genome site: synonymous sites
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Close contact;Household contact;Non-household contact;Occupation
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Unspecified
Risk factor adjustment: Unspecified
Population group: Persons under investigation
Sample type: Community based
Sample size: 1112
Country: China
Location: Beijing
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Lower bound: 6.3
Upper bound: 28.8
Bounds: 6.3 - 28.8
Epidemic phase: Unspecified
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Contact based
Sample size: 669
Country: China
Location: Beijing
Study period:   2003 to 23 May-05 2023
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 0
Lower bound: 0
Upper bound: 0
Bounds: 0 - 0
Epidemic phase: Unspecified
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Contact based
Sample size: 363
Country: China
Location: Beijing
Study period:   2003 to 23 May-05 2023
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 3.8
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 55
CFR/IFR denominator: 1454
CFR/IFR method: Naive
Population group: General population
Sample type: Community based
Sex: Both
Minimum age: 18
Maximum age: 92
Sample size: 1454
Country: China
Location: Foshan municipality, Guangdong Province
Study period: 16 Nov-11 2002 to 30 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 12.7
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR method: Naive
Population group: General population
Sample type: Community based
Sex: Both
Minimum age: 65
Maximum age: 92
Country: China
Location: Foshan municipality, Guangdong Province
Study period: 16 Nov-11 2002 to 30 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 13
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 13
Upper bound: 72.7
Bounds: 13 - 72.7
Population group: Animal workers
Sample type: Trade / business based
Country: China
Location: Foshan municipality, Guangdong Province
Study period: 16 Nov-11 2002 to 30 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 1.2
Unit: Percentage (%)
Value type: Unspecified
Population group: General population
Sample type: Community based
Country: China
Location: Foshan municipality, Guangdong Province
Study period: 16 Nov-11 2002 to 30 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: General population
Sample type: Community based
Sex: Both
Minimum age: 0
Maximum age: 86
Sample size: 662
Country: China
Location: Foshan municipality, Guangdong Province
Study period: 16 Nov-11 2002 to 30 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - time in care (length of stay)
Parameter value: 23.1
Unit: Days
Value type: Mean
Lower bound: 5
Upper bound: 78
Bounds: 5 - 78
Uncertainty single value: 11.9 (Other)
Combined uncertainty: 11.9 (Other)
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 20
Maximum age: 75
Sample size: 78
Country: China
Location: Guangdong
Study period: 22 Dec-12 2002 to  Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 2.4
Unit: Days
Value type: Mean
Lower bound: 1
Upper bound: 5
Bounds: 1 - 5
Uncertainty single value: 1.5 (Other)
Combined uncertainty: 1.5 (Other)
Population group: General population
Sample type: Hospital based
Minimum age: 20
Maximum age: 75
Sample size: 17
Country: China
Location: Guangdong
Study period: 22 Dec-12 2002 to  Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 9
Unit: Percentage (%)
CFR/IFR numerator: 7
CFR/IFR denominator: 78
CFR/IFR method: Naive
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 20
Maximum age: 75
Sample size: 78
Country: China
Location: Guangdong
Study period: 22 Dec-12 2002 to  Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Age;Cormobidity
Risk factor outcome: Severe disease
Risk factor occupation: Unspecified
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 20
Maximum age: 75
Sample size: 78
Country: China
Location: Guangdong
Study period: 22 Dec-12 2002 to  Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 5.9
Unit: Days
Value type: Mean
Lower bound: 1
Upper bound: 20
Bounds: 1 - 20
Uncertainty single value: 3.5 (Standard Deviation)
Combined uncertainty: 3.5 (Standard Deviation)
Epidemic phase: Unspecified
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Sample size: 96
Country: China
Location: Guangzhou
Study period: 30 Jan-01 2003 to 10 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 2.9
Unit: Days
Value type: Mean
Lower bound: 1
Upper bound: 10
Bounds: 1 - 10
Uncertainty single value: 2 (Standard Deviation)
Combined uncertainty: 2 (Standard Deviation)
Epidemic phase: Unspecified
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Sample size: 96
Country: China
Location: Guangzhou
Study period: 30 Jan-01 2003 to 10 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - time in care (length of stay)
Parameter value: 17.2
Unit: Days
Value type: Mean
Lower bound: 8
Upper bound: 47
Bounds: 8 - 47
Uncertainty single value: 8 (Standard Deviation)
Combined uncertainty: 8 (Standard Deviation)
Epidemic phase: Unspecified
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Sample size: 96
Country: China
Location: Guangzhou
Study period: 30 Jan-01 2003 to 10 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 1
Unit: Percentage (%)
CFR/IFR numerator: 1
CFR/IFR denominator: 96
CFR/IFR method: Naive
Epidemic phase: Unspecified
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Sample size: 96
Country: China
Location: Guangzhou
Study period: 30 Jan-01 2003 to 10 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Contact with animal;Other
Risk factor outcome: Probable case
Risk factor occupation: Unspecified
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 14
Maximum age: 84
Sample size: 375
Country: China
Location: Beijing
Study period: 28 Apr-04 2003 to 4 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Cormobidity;Other
Risk factor outcome: Probable case
Risk factor occupation: Unspecified
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 14
Maximum age: 84
Sample size: 375
Country: China
Location: Beijing
Study period: 28 Apr-04 2003 to 4 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Contact with animal;Cormobidity;Other
Risk factor outcome: Probable case
Risk factor occupation: Unspecified
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 14
Maximum age: 84
Sample size: 375
Country: China
Location: Beijing
Study period: 28 Apr-04 2003 to 4 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Other
Risk factor outcome: Probable case
Risk factor occupation: Unspecified
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 14
Maximum age: 84
Sample size: 375
Country: China
Location: Beijing
Study period: 28 Apr-04 2003 to 4 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 26
Unit: Percentage (%)
CFR/IFR numerator: 8
CFR/IFR denominator: 31
CFR/IFR method: Naive
Epidemic phase: Unspecified
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 14
Maximum age: 84
Sample size: 31
Country: China
Location: Beijing
Study period: 28 Apr-04 2003 to 28 Aug-08 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IFA
Parameter value: 0
Unit: Percentage (%)
Uncertainty type: 95% CI
Uncertainty lower value: 0
Uncertainty upper value: 0.6
Combined uncertainty: 0 - 0.6 (95% CI)
CFR/IFR numerator: 0
CFR/IFR denominator: 29
Population group: Healthcare workers
Sex: Unspecified
Sample size: 29
Country: Hong Kong SAR,  China
Study period: 22 May-05 2003 to 31 May-05 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 5.1
Unit: Percentage (%)
CFR/IFR numerator: 29
CFR/IFR denominator: 574
Population group: Healthcare workers
Sex: Both
Minimum age: 25
Maximum age: 79
Sample size: 574
Country: Hong Kong SAR,  China
Study period: 22 May-05 2003 to 31 May-05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Close contact;Other
Risk factor outcome: Superspreading
Risk factor occupation: Unspecified
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 124
Country: China, Hong Kong SAR,  China
Location: Guangzhou, Hong-Kong
Study period:  Sep-09 2004 to  Nov-11 2005
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Cormobidity;Other
Risk factor outcome: Superspreading
Risk factor occupation: Unspecified
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 124
Country: China, Hong Kong SAR,  China
Location: Guangzhou, Hong-Kong
Study period:  Sep-09 2004 to  Nov-11 2005
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Disaggregated by: Region
Risk factor: Close contact;Other
Risk factor outcome: Superspreading
Risk factor occupation: Unspecified
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 124
Country: China, Hong Kong SAR,  China
Location: Guangzhou, Hong-Kong
Study period:  Sep-09 2004 to  Nov-11 2005
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Disaggregated by: Region
Risk factor: Other
Risk factor outcome: Superspreading
Risk factor occupation: Unspecified
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 124
Country: China, Hong Kong SAR,  China
Location: Guangzhou, Hong-Kong
Study period:  Sep-09 2004 to  Nov-11 2005
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Male
Minimum age: 19
Maximum age: 90
Sample size: 74
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital
Study period: 4 Mar-03 2003 to  Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 40.5
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 18.2
Upper bound: 65
Bounds: 18.2 - 65
Epidemic phase: Unspecified
Disaggregated by: Other, Time
Population group: Persons under investigation
Sample type: Hospital based
Sex: Male
Minimum age: 19
Maximum age: 90
Sample size: 74
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital
Study period: 4 Mar-03 2003 to  Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Cormobidity;Other
Risk factor outcome: Infection
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Male
Minimum age: 19
Maximum age: 90
Sample size: 74
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital
Study period: 4 Mar-03 2003 to  Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Community based
Sample size: 187
Country: Hong Kong SAR,  China
Location: Amoy Gardens
Study period: 21 Mar-03 2003 to 1 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Other
Risk factor outcome: Infection
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Community based
Sample size: 187
Country: Hong Kong SAR,  China
Location: Amoy Gardens
Study period: 21 Mar-03 2003 to 1 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 12.5
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 1
CFR/IFR denominator: 8
CFR/IFR method: Naive
Epidemic phase: Unspecified
Sample size: 8
Country: Taiwan,  China
Study period: 1 May-05 2003 to 20 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 5
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 1
CFR/IFR denominator: 20
CFR/IFR method: Naive
Epidemic phase: Unspecified
Sample size: 20
Country: China
Study period: 27 Mar-03 2003 to 4 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 12.5
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 1
CFR/IFR denominator: 8
CFR/IFR method: Naive
Epidemic phase: Unspecified
Sample size: 8
Country: Canada
Study period: 17 Mar-03 2003 to 4 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 17
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 15
Upper bound: 25
Bounds: 15 - 25
CFR/IFR numerator: 299
CFR/IFR denominator: 1755
CFR/IFR method: Unspecified
Epidemic phase: Unspecified
Disaggregated by: Time
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 1755
Country: Hong Kong SAR,  China
Location: Hong Kong
Study period: 12 Mar-03 2003 to 31 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 8
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 191
CFR/IFR denominator: 2521
CFR/IFR method: Unspecified
Epidemic phase: Unspecified
Disaggregated by: Time
Population group: Persons under investigation
Sample type: Unspecified
Sex: Unspecified
Sample size: 2521
Country: China
Location: Beijing
Study period: 21 Apr-04 2003 to 2 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Mutations
Parameter type: Mutations – mutation rate
Unit: Mutations/genome/generation (U)
Value type: Unspecified
Lower bound: 0.11
Upper bound: 0.07
Bounds: 0.11 - 0.07
Population group: Persons under investigation
Sample type: Mixed settings
Sex: Unspecified
Sample size: 10
Country: Taiwan,  China
Location: Taiwan
Study period:  Mar-03 2003 to  Jun-06 2003
Genome site: whole genome
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 92.7
Unit: Percentage (%)
CFR/IFR numerator: 38
CFR/IFR denominator: 41
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 24
Maximum age: 87
Sample size: 41
Country: Taiwan,  China
Location: NTUH, Northern Taiwan
Study period: 8 Mar-03 2003 to 15 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 3
Unit: Days
Value type: Median
Uncertainty type: Range
Uncertainty lower value: 1
Uncertainty upper value: 12
Combined uncertainty: 1 - 12 (Range)
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 24
Maximum age: 87
Sample size: 76
Country: Taiwan,  China
Location: `
Study period: 8 Mar-03 2003 to 15 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 78.6
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 11
CFR/IFR denominator: 14
CFR/IFR method: Unspecified
Epidemic phase: Unspecified
Population group: Other
Sample type: Hospital based
Sex: Both
Minimum age: 24
Maximum age: 87
Sample size: 14
Country: Taiwan,  China
Location: NTUH, Northern Taiwan
Study period: 8 Mar-03 2003 to 15 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 6.5
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 4
CFR/IFR denominator: 62
CFR/IFR method: Unspecified
Epidemic phase: Unspecified
Population group: Other
Sample type: Hospital based
Sex: Both
Minimum age: 24
Maximum age: 87
Sample size: 62
Country: Taiwan,  China
Location: NTUH, Northern Taiwan
Study period: 8 Mar-03 2003 to 15 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>death
Parameter value: 12
Unit: Days
Value type: Median
Uncertainty type: Range
Uncertainty lower value: 4
Uncertainty upper value: 42
Combined uncertainty: 4 - 42 (Range)
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 24
Maximum age: 87
Sample size: 15
Country: Taiwan,  China
Location: NTUH, Northern Taiwan
Study period: 8 Mar-03 2003 to 15 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Cormobidity;Other;Sex
Risk factor outcome: Other
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 24
Maximum age: 87
Sample size: 76
Country: Taiwan,  China
Location: NTUH, Northern Taiwan
Study period: 8 Mar-03 2003 to 15 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Other
Risk factor outcome: Other
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 24
Maximum age: 87
Sample size: 76
Country: Taiwan,  China
Location: NTUH, Northern Taiwan
Study period: 8 Mar-03 2003 to 15 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Other
Risk factor outcome: Other
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 24
Maximum age: 87
Sample size: 76
Country: Taiwan,  China
Location: NTUH, Northern Taiwan
Study period: 8 Mar-03 2003 to 15 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Cormobidity;Other;Sex
Risk factor outcome: Other
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 24
Maximum age: 87
Sample size: 76
Country: Taiwan,  China
Location: NTUH, Northern Taiwan
Study period: 8 Mar-03 2003 to 15 Jun-06 2003